Thromb Haemost 2016; 116(05): 967-974
DOI: 10.1160/TH16-03-0205
Stroke, Systemic or Venous Thromboembolism
Schattauer GmbH

Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France

Aurélien Delluc
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Cécile Tromeur
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Florent Le Ven
3   Department of Cardiology, Brest University Hospital, Brest, France
,
Maelenn Gouillou
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Nicolas Paleiron
5   Respirology unit, Brest Military Hospital “Clermont-Tonnerre”, BCRM Brest, CC41, Brest, France
,
Luc Bressollette
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Michel Nonent
6   Department of Radiology, Brest University Hospital, Brest, France
,
Pierre-Yves Salaun
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
7   Department of Nuclear Medicine, Brest University Hospital, Brest, France
,
Karine Lacut
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Christophe Leroyer
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
,
Grégoire Le Gal
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Francis Couturaud
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
2   Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
Dominique Mottier
1   Brest University (Université de Bretagne Occidentale), Groupe d’Etude de la Thrombose de Bretagne Occidentale, Equipe d’Accueil 3878, Brest, France
4   Centre d’Investigation Clinique INSERM 1412, Brest University Hospital, Brest, France
,
for the EPIGETBO study group › Author Affiliations
Further Information

Publication History

Received: 11 March 2016

Accepted after major revision: 04 July 2016

Publication Date:
11 November 2017 (online)

Summary

In 1998 we estimated the incidence of venous thromboembolism (VTE) to be 1.8/1,000 per year. The aim of this study was to compare current VTE incidence to that observed in 1998. We prospectively recorded all cases of symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) of the lower limbs diagnosed between March 1, 2013 and February 28, 2014 in hospitals and in the community, using the same method and geographic area than in 1998. The 2013 incidence rates of VTE were computed and compared with those of 1998 using age- and sex-specific standardised incidence ratios (SIRs). In 2013, we recorded 576 VTE cases (279 isolated DVT and 297 PE ± DVT). Among 367,911 inhabitants, the overall incidence of VTE was 1.57/1,000 (95 % CI 1.44–1.69). The overall VTE incidence was significantly lower in 2013 as compared with 1998: SIR 0.72 (95 % CI 0.67–0.79) as well as the incidence of isolated DVT: SIR 0.53 (95 % CI 0.47–0.60); conversely, the overall incidence of PE was unchanged: SIR 1.10 (95 % CI, 0.98–1.23) despite an increase in the incidence of isolated PE: SIR 1.29 (95 % CI, 1.10–1.52). In 1998, 4.4 % of PE cases were diagnosed using CTPA as compared with 73.7 % in 2013 (p < 0.001). In conclusion, between 1998 and 2013, the incidence of symptomatic DVT decreased. Conversely, we found no similar reduction in the incidence of symptomatic PE; whether this is due to changes in diagnostic tests and algorithms in the management of suspected PE requires further investigations.

Supplementary Material to this paper is available online at www.thrombosis-online.com.

 
  • References

  • 1 Gillum RF. Pulmonary embolism and thrombophlebitis in the United States, 1970-1985. Am Heart J 1987; 114: 1262-1264.
  • 2 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
  • 3 Laporte S, Mismetti P, Decousus H. et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716.
  • 4 Kahn SR, Ducruet T, Lamping DL. et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med 2005; 165: 1173-1178.
  • 5 Lang IM, Pesavento R, Bonderman D. et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Resp J 2013; 41: 462-468.
  • 6 Shojania KG, Duncan BW, McDonald KM. et al. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. AHRQ Publication No 01-E058 2001
  • 7 Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBO Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-660.
  • 8 Cohen AT, Agnelli G, Anderson FA. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
  • 9 ThePIOPEDInvestigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). J Am Med Assoc 1990; 263: 2753-2759.
  • 10 Bajc M, Neilly JB, Miniati M. et al. EANM guidelines for ventilation/perfusion scintigraphy : Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nuclear Med Mol Imaging 2009; 36: 1356-1370.
  • 11 Le Gal G, Righini M, Sanchez O. et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006; 95: 963-966.
  • 12 www.insee.fr/fr/themes/tableau_local.asp?ref_id=POP1B&millesime=2011&niveau=1&typgeo=ARR&codgeo=291
  • 13 Cohen AT, Davidson BL, Gallus AS. et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. Br Med J 2006; 332: 325-329.
  • 14 Leizorovicz A, Cohen AT, Turpie AG. et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-879.
  • 15 Samama MM, Cohen AT, Darmon JY. et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
  • 16 Oger E, Bressollette L, Nonent M. et al. High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients. Thromb Haemost 2002; 88: 592-597.
  • 17 Jauch EC, Saver JL, Adams Jr HP. et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
  • 18 Lannon R, Smyth A, Mulkerrin EC. An audit of the impact of a stroke unit in an acute teaching hospital. Irish J Med Sci 2011; 180: 37-40.
  • 19 Sheh SH, Bellin E, Freeman KD. et al. Pulmonary embolism diagnosis and mortality with pulmonary CT angiography versus ventilation-perfusion scintigraphy: evidence of overdiagnosis with CT?. Am J Roentgenol 2012; 198: 1340-1345.
  • 20 Anderson DR, Kahn SR, Rodger MA. et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. J Am Med Assoc 2007; 298: 2743-2753.
  • 21 Huang W, Goldberg RJ, Anderson FA. et al. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985–2009). Am J Med 2014; 127: 829-839 e5.
  • 22 Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171: 831-837.
  • 23 Alotaibi GS, Wu C, Senthilselvan A. et al. Secular trends in incidence and mortality of acute venous thromboembolism: The AB-VTE population based study. Am J Med 2016 Epub ahead of print..
  • 24 Deitelzweig SB, Johnson BH, Lin J. et al. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol 2011; 86: 217-220.
  • 25 Dentali F, Ageno W, Pomero F. et al. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost 2016; 115: 399-405.
  • 26 Huang W, Goldberg RJ, Cohen AT. et al. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009). Thromb Res 2015; 135: 1100-1106.
  • 27 Santosa F, Moysidis T, Moerchel C. et al. Pulmonary embolism in young people. Trends in Germany from 2005 to 2011. Trends in Germany from 2005 to 2011. Hamostaseologie 2014; 34: 88-92.
  • 28 Shiraev TP, Omari A, Rushworth RL. Trends in pulmonary embolism morbidity and mortality in Australia. Thromb Res 2013; 132: 19-25.
  • 29 Silverstein MD, Heit JA, Mohr DN. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
  • 30 Huerta C, Johansson S, Wallander MA. et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167: 935-943.
  • 31 Naess IA, Christiansen SC, Romundstad P. et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 05: 692-699.
  • 32 Tagalakis V, Patenaude V, Kahn SR. et al. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med 2013; 126: 832 e13-21
  • 33 Cushman M, Tsai AW, White RH. et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
  • 34 Janke RM, McGovern PG, Folsom AR. Mortality, hospital discharges, and case fatality for pulmonary embolism in the Twin Cities: 1980-1995. J Clin Epidemiol 2000; 53: 103-109.